COVID

A possible biomarker for long COVID suggests some people with the condition never fully cleared the virus

People who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness

Amid COVID, studies in Denmark suggest that crowds do not always engage in bad behavior—and that mass-gatherings sometimes offer meaningful connection

A growing mortality gap between Republican and Democratic areas may largely stem from policy choices

With infections still surging, the U.S. needs to invest in this technology to prepare for the next variants

On this episode of the COVID, Quickly podcast, we talk about the increase in new Omicron subvariants. Should fall vaccine boosters contain standard Omicron or some of those new subvariants instead?

Developing nations that desperately need these more effective vaccines are virtually locked out

A technique that detects coronavirus strains circulating in a community could become an early-warning system

The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?

This Supreme Court often ignores science when handing down decisions, and it affects far too many lives

Scientists in Thailand have established that a tabby passed SARS-CoV-2 to a veterinary surgeon—although such cases of cat-to-human transmission are probably rare

The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron’s BA.2 subvariant and the Alpha variant